Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bismuth interacts with a broad range of bacterial enzymes and proteins, primarily by binding to thiol groups and displacing essential metals (such as Zn²⁺) in metalloenzymes. This can inhibit critical bacterial enzymes including urease (important for Helicobacter pylori survival), malate dehydrogenase, succinyl-CoA synthase, fumarase, and various chaperones and metal-binding proteins[1][2][3][4][5][7]. The inhibition can be both competitive and irreversible, depending on the enzyme and the bismuth complex involved[4][5]. Bismuth's broad ability to target multiple proteins underlies its unique utility as a multi-target antibacterial agent, particularly in treating infections like H. pylori and in inhibiting metallo-β-lactamases (MBLs) that contribute to antibiotic resistance[5]. Additional context: - While bismuth itself is not a single-target drug, it targets a functional class (bacterial proteins/enzymes with accessible thiols or metal cofactors). - There is no single canonical protein or gene for “bacterial enzymes/proteins via bismuth binding”—the mechanism is multi-target and species-dependent. - This designation is therefore **non-specific and would be flagged as "is_incorrect: true"** for purposes where an individual, well-defined target is required. If more specificity is needed, individual proteins (e.g., "Urease (H. pylori)", "NDM-1 metallo-β-lactamase") should be used.
Inhibition of enzymatic activity via bismuth coordination, particularly with cysteine residues in active sites; Metal displacement from bacterial metalloenzymes (e.g., replacing essential zinc); Disruption of thiol/metal-binding protein function[4][5][7]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bismuth-binding bacterial enzymes and proteins (null).